Zymeworks Hosts R&D Day Highlighting Continued Clinical Progress in Oncology Programs and Expansion into Autoimmune and Inflammatory Diseases Notified -
EBC Financial Group Launches US Stocks, Empowering Global CFD Traders to Invest in Top US Companies Notified -
Essential Pharma announces €900 million recapitalisation through a Gyrus Capital Continuation Vehicle led by AlpInvest and new strategic financing from Sixth Street Notified -
Io Therapeutics, Inc., announces presentation of data from studies of its RAR gamma agonist compound IRX5010 in treatment of a mouse model of triple negative breast cancer, demonstrating combination treatment effects with an anti-PDL-1 monoclonal antibody Notified -
Io Therapeutics, Inc., announces presentation of data from studies of its RAR gamma agonist compound IRX5010 in treatment of a mouse model of triple negative breast cancer, demonstrating combination treatment effects with an anti-PDL-1 monoclonal antibody Notified -
Harbert South Bay Capitalizes Development of The James Luxury Seniors Housing Community in Southern California Notified -
RM11 Redefines the Creator Economy with Invitation-Only Access and Industry-Leading Payouts Notified -